IVF used by some to avoid passing on genetic diseases to offspring
By Jamie Talan,
The Washington Post
| 12. 04. 2021
By Fotograf Kallestad, Gorm / NTB Scanpix. CC BY NC 4.0
In vitro fertilization (IVF), widely known as a way to help infertile couples have babies, has taken on another remarkable use: It has become part of a procedure to help families keep from passing on serious genetic diseases to their children.
Parents who know they carry genetic mutations for muscular dystrophy, cystic fibrosis, sickle cell anemia, breast cancer, Huntington’s disease, Alzheimer’s and other inherited diseases can undergo IVF, where the mother’s eggs are collected and combined with sperm in a dish, and another procedure called preimplantation genetic testing (PGT), in which embryos are screened for the particular mutation and only disease-free embryos can be implanted in the mother.
“I don’t know why more people don’t embrace these technologies,” said Greg McGuire, 38, of Fishers, Ind., who was diagnosed with Becker muscular dystrophywhen he was 8 years old, one of several family members with the inherited genetic mutation. Because it is passed down from mother to son — and his mother only had sisters — no one in the...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...